Onderzoeker
Bouke de Jong
Affiliaties
- Mycobacteriologie (Onderzoekseenheid)
Lid
Vanaf1 sep 2010 → Heden - Mycobacteriologie (Onderzoekseenheid)
Lid
Vanaf31 aug 2010 → 16 apr 2015
Projecten
21 - 30 of 75
- EndTB-Q Output 5 testing new regimens to treat MDR-TB resistant to fluoroquinilonesVanaf1 jul 2020 → Heden
- MSF Routine ServicesVanaf1 mrt 2020 → 28 feb 2024
- Heteroresistentie : occulte bedreiging voor succesvolle behandeling van resistente tuberculosisVanaf1 jan 2020 → 31 dec 2023
- Alternative techniques for monitoring of rifampicin resistant TB treatment response, to replace systematic monitoring by cultureVanaf1 jan 2020 → 31 dec 2020
- Innovative diagnostic and therapeutic measures to improve MDR-TB diagnosis and management in Conakry, GuineaVanaf1 jan 2020 → Heden
- Document false rifampicin resistance of Xpert MTB/RIF in BangladeshVanaf1 jan 2020 → 31 dec 2020
- Effectiveness and tolerability of a short regimen for drug resistant tuberculosis treatment in Kandahar Province, Afghanistan, Uncontrolled Clinical StudyVanaf1 sep 2019 → 30 apr 2022
- Technical assistance and support by the SRL ITM to the NRLs of Georgia and Bangladesh and Proficiency testing for Drug-susceptibility testing (Round 25)Vanaf15 mei 2019 → 31 mei 2020
- Het in kaart brengen van de transmissiedynamiek van Mycobacterium leprae in de Comoren met behulp van innovatieve moleculaire techniekenVanaf11 apr 2019 → Heden
- Treatment of Rifampin-resistsant Tuberculosis with an All-Oral Regimen containing new drugs in Zhytomyr UkraineVanaf1 mrt 2019 → 31 jul 2021
Publicaties
1 - 10 van 167
- Protocol, rationale and design of BE-PEOPLE (Bedaquiline enhanced exposure prophylaxis for LEprosy in the Comoros): a cluster randomized trial on effectiveness of rifampicin and bedaquiline as post-exposure prophylaxis of leprosy contacts(2023)
Auteurs: Assoumani Younoussa, Said Nourdine Samidine, Auke T Bergeman, Alberto Piubello, Nissad Attoumani, Silahi Halifa Grillone, Sofie Braet, Achilleas Tsoumanis, Abdallah Baco, Aboubacar Mzembaba, et al.
Pagina's: 310 - Community-supported self-administered tuberculosis treatment combined with active tuberculosis screening: a pilot experience in Conakry, Guinea(2023)
Auteurs: Souleymane Hassane-Harouna, Tinne Gils, Tom Decroo, Nimer Ortuno-Gutierrez, Alexandre Delamou, Gba-Foromo Cherif, Lansana Mady Camara, Leen Rigouts, Bouke de Jong
- Rifampicin resistance conferring mutations among Mycobacterium tuberculosis strains in Rwanda(2023)
Auteurs: Isabel Cuella Martin, Jean Claude Semuto Ngabonziza, Gabriela Torrea, Conor J. Meehan, Wim Mulders, Bertin Ushizimpumu, Louise De Weerdt, Jelle Keysers, Willem Bram de Rijk, Tom Decroo, et al.
Pagina's: 274-281 - Borderline rpoB mutations transmit at the same rate as common rpoB mutations in a tuberculosis cohort in Bangladesh(2023)
Auteurs: Pauline Lempens, Armand Van Deun, Kya J M Aung, Mohammad A Hossain, Mahboobeh Behruznia, Tom Decroo, Leen Rigouts, Bouke de Jong, Conor J. Meehan
- Mycobacterium tuberculosis retains viability in RNAlater buffer but not in GTC-TCEP and DNA/RNA Shield(2023)
Auteurs: Lena Krausser, Sofie Braet, Z Benaamar, Magalie Van Dyck-Lippens, Bouke de Jong, Leen Rigouts
Pagina's: 115905 - GeneXpert MTB/RIF Ultra performance to detect uncommon rpoB mutations in Mycobacterium tuberculosis(2023)
Auteurs: Leen Rigouts, Jelle Keysers, Rabab Reenaers, Kristina Fissette, Armand Van Deun, Bouke de Jong
- Face mask sampling (FMS) for tuberculosis shows lower diagnostic sensitivity than sputum sampling in Guinea(2023)
Auteurs: Souleymane Hassane-Harouna, Sofie Braet, Tom Decroo, Lansana Mady Camara, Alexandre Delamou, Sven De Bock, Nimer Ortuno-Gutierrez, Gba-Foromo Cherif, Caroline M Williams, Anika Wisniewska, et al.
- Bedaquiline- and clofazimine- selected Mycobacterium tuberculosis mutants: further insights on resistance driven largely by Rv0678(2023)
Auteurs: Jihad Snobre, M C Villellas, Nele Coeck, Wim Mulders, O Tzfadia, Bouke de Jong, K Andries, Leen Rigouts
- Re-evaluation of critical concentrations of antituberculosis fluoroquinolones in the mycobacteria growth indicator tube 960 System(2023)
Auteurs: Rupasinghe Arachchige Praharshinie Rupasinghe, Jens Vereecken, Bouke de Jong, Leen Rigouts, Michèle Driesen
Pagina's: 316-323 - High rate of adverse drug reactions with a novel tuberculosis retreatment regimen combining triple-doses of both isoniazid and rifampicin(2023)
Auteurs: Mahamadou Bassirou Souleymane, Sani Kadri, Alberto Piubello, Achilleas Tsoumanis, Alphazazi Soumana, Hamidou Issa, Abdoulaziz Kabirou Amoussa, Armand Van Deun, Lut Lynen, Bouke de Jong, et al.
Pagina's: 78-81